NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve 1. To consider and take on record the Un-audited Financial Results of the Company for quarter and nine months ended 31st December 2022. 2. Any other business with the permission of the Chair.

pdf

Norris Medicines Ltd.

13 Jan 2023

17.07

3.83%

Company Update

NORRIS MEDICINES LTD. - 524414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Submission as per Regulation 74(5) of SEBI (DP) Regulations, 2018

pdf

Norris Medicines Ltd.

06 Jan 2023

17.07

3.83%

Result

NORRIS MEDICINES LTD. - 524414 - Results-Financial Results For Sep 30, 2022

BSE India

Results-Financial Results for Sep 30, 2022, resubmitted as per BSE''s email.

pdf

Norris Medicines Ltd.

30 Dec 2022

17.07

3.83%

SAST

NORRIS MEDICINES LTD. - 524414 - Closure of Trading Window

BSE India

Submission of Closure of Trading Window

pdf

Norris Medicines Ltd.

25 Nov 2022

17.07

3.83%

Company Update

NORRIS MEDICINES LTD. - 524414 - Appointment of Company Secretary and Compliance Officer

BSE India

Prerna Karwa has been appointed as the Company Secretary and Compliance officer of the Company w.e.f. today i.e. 25-11-2022. Details of her appointment are enclosed herewith.

pdf

Is Norris Medicines Ltd. worth buying?

7 Votes:

Buy 71.43%

Sell 14.29%

Hold 14.29%